Effect of pioglitazone on glucose metabolism and luteinizing hormone secretion in women with polycystic ovary syndrome

This publication has 45 references indexed in Scilit:

• Sustained effects of pioglitazone vs. glibenclamide on insulin sensitivity, glycaemic control, and lipid profiles in patients with Type 2 diabetes
  Diabetic Medicine, 2004
• Cellular mechanisms of insulin resistance
  Journal of Clinical Investigation, 2000
• cis-FFA do not alter membrane depolarization but block Ca2+ influx and GH secretion in KCl-stimulated somatotroph cells.: Suggestion for a direct cis-FFA perturbation of the Ca2+ channel opening
  Biochimica et Biophysica Acta (BBA) - Biomembranes, 1997
• Role of Growth Hormone in Polycystic Ovarian Syndrome
  Seminars in Reproductive Medicine, 1997
• Decreases in Ovarian Cytochrome P450c17α Activity and Serum Free Testosterone after Reduction of Insulin Secretion in Polycystic Ovary Syndrome
  New England Journal of Medicine, 1996
• Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle. A potential mechanism for insulin resistance in the polycystic ovary syndrome.
  Journal of Clinical Investigation, 1995
• Serum lipoprotein lipid profile in women with the polycystic ovary syndrome: relation to anthropometric, endocrine and metabolic variables
  Clinical Endocrinology, 1994
• Assessment of Glucose Turnover Rates in Euglycaemic Clamp Studies using Primed-constant [3-³H]-glucose Infusion and Labelled or Unlabelled Glucose Infusates
  Diabetic Medicine, 1992
• Decreased insulin activation of glycogen synthase in skeletal muscles in young nonobese Caucasian first-degree relatives of patients with non-insulin-dependent diabetes mellitus.
  Journal of Clinical Investigation, 1992
• ABNORMAL ANDROGEN AND OESTROGEN METABOLISM IN MEN WITH STEROID SULPHATASE DEFICIENCY AND RECESSIVE X‐LINKED ICHTHYOSIS
  Clinical Endocrinology, 1985